Literature DB >> 1331176

Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance.

M J Saad1, E Araki, M Miralpeix, P L Rothenberg, M F White, C R Kahn.   

Abstract

Insulin rapidly stimulates tyrosine phosphorylation of a protein of approximately 185 kD in most cell types. This protein, termed insulin receptor substrate-1 (IRS-1), has been implicated in insulin signal transmission based on studies with insulin receptor mutants. In the present study we have examined the levels of IRS-1 and the phosphorylation state of insulin receptor and IRS-1 in liver and muscle after insulin stimulation in vivo in two rat models of insulin resistance, i.e., insulinopenic diabetes and fasting, and a mouse model of non-insulin-dependent diabetes mellitus (ob/ob) by immunoblotting with anti-peptide antibodies to IRS-1 and anti-phosphotyrosine antibodies. As previously described, there was an increase in insulin binding and a parallel increase in insulin-stimulated receptor phosphorylation in muscle of fasting and streptozotocin-induced (STZ) diabetic rats. There was also a modest increase in overall receptor phosphorylation in liver in these two models, but when normalized for the increase in binding, receptor phosphorylation was decreased, in liver and muscle of STZ diabetes and in liver of 72 h fasted rats. In the hyperinsulinemic ob/ob mouse there was a decrease in insulin binding and receptor phosphorylation in both liver and muscle. The tyrosyl phosphorylation of IRS-1 after insulin stimulation reflected an amplification of the receptor phosphorylation in liver and muscle of hypoinsulinemic animals (fasting and STZ diabetes) with a twofold increase, and showed a significant reduction (approximately 50%) in liver and muscle of ob/ob mouse. By contrast, the levels of IRS-1 protein showed a tissue specific regulation with a decreased level in muscle and an increased level in liver in hypoinsulinemic states of insulin resistance, and decreased levels in liver in the hyperinsulinemic ob/ob mouse. These data indicate that: (a) IRS-1 protein levels are differentially regulated in liver and muscle; (b) insulin levels may play a role in this differential regulation of IRS-1; (c) IRS-1 phosphorylation depends more on insulin receptor kinase activity than IRS-1 protein levels; and (d) reduced IRS-1 phosphorylation in liver and muscle may play a role in insulin-resistant states, especially of the ob/ob mice.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331176      PMCID: PMC443244          DOI: 10.1172/JCI116060

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Purification and partial sequence analysis of pp185, the major cellular substrate of the insulin receptor tyrosine kinase.

Authors:  P L Rothenberg; W S Lane; A Karasik; J Backer; M White; C R Kahn
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Divergent molecular mechanisms for insulin-resistant glucose transport in muscle and adipose cells in vivo.

Authors:  M J Charron; B B Kahn
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

4.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

5.  Immunological detection of phosphotyrosine-containing proteins in rat livers after insulin injection.

Authors:  K Tobe; O Koshio; Y Tashiro-Hashimoto; F Takaku; Y Akanuma; M Kasuga
Journal:  Diabetes       Date:  1990-05       Impact factor: 9.461

6.  Insulin binding and receptor tyrosine kinase activity in rat liver and skeletal muscle: effect of starvation.

Authors:  M Balage; J Grizard; C Sornet; J Simon; D Dardevet; M Manin
Journal:  Metabolism       Date:  1990-04       Impact factor: 8.694

7.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity.

Authors:  M F White; J N Livingston; J M Backer; V Lauris; T J Dull; A Ullrich; C R Kahn
Journal:  Cell       Date:  1988-08-26       Impact factor: 41.582

8.  Dexamethasone-induced changes in phosphorylation of the insulin and epidermal growth factor receptors and their substrates in intact rat hepatocytes.

Authors:  A Karasik; C R Kahn
Journal:  Endocrinology       Date:  1988-11       Impact factor: 4.736

9.  Effects of hypercortisolemia and diabetes on skeletal muscle insulin receptor function in vitro and in vivo.

Authors:  N E Block; M G Buse
Journal:  Am J Physiol       Date:  1989-01

10.  Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation.

Authors:  H Maegawa; J M Olefsky; S Thies; D Boyd; A Ullrich; D A McClain
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

View more
  78 in total

1.  Regulation of insulin-stimulated tyrosine phosphorylation of Shc and Shc/Grb2 association in liver, muscle, and adipose tissue of epinephrine- and streptozotocin-treated rats.

Authors:  V Páez-Espinosa; E M Rocha; L A Velloso; M J Saad
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

2.  Regulation of insulin receptor substrate-2 tyrosine phosphorylation in animal models of insulin resistance.

Authors:  Fernanda Alvarez Rojas; Aparecida Emiko Hirata; Mario J A Saad
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

3.  Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes.

Authors:  J M Ricort; J F Tanti; E Van Obberghen; Y Le Marchand-Brustel
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

4.  In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes.

Authors:  Kwang-Hoon Chun; Kang-Duk Choi; Dae-Ho Lee; Yoonshin Jung; Robert R Henry; Theodore P Ciaraldi; Young-Bum Kim
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-12-28       Impact factor: 4.310

5.  Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism.

Authors:  Cullen M Taniguchi; Kohjiro Ueki; Ronald Kahn
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

6.  Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance.

Authors:  Maria Helena M Lima; Mirian Ueno; Ana Cláudia P Thirone; Eduardo M Rocha; Carla Roberta O Carvalho; Mário J A Saad
Journal:  Endocrine       Date:  2002-06       Impact factor: 3.633

7.  Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo.

Authors:  F Giorgino; A Almahfouz; L J Goodyear; R J Smith
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

Authors:  Maria D'Apolito; Xueliang Du; Haihong Zong; Alessandra Catucci; Luigi Maiuri; Tiziana Trivisano; Massimo Pettoello-Mantovani; Angelo Campanozzi; Valeria Raia; Jeffrey E Pessin; Michael Brownlee; Ida Giardino
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

9.  Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.

Authors:  R Burcelin; M Eddouks; J Maury; J Kande; R Assan; J Girard
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

10.  Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.

Authors:  Qiu-Lan Ma; Fusheng Yang; Emily R Rosario; Oliver J Ubeda; Walter Beech; Dana J Gant; Ping Ping Chen; Beverly Hudspeth; Cory Chen; Yongle Zhao; Harry V Vinters; Sally A Frautschy; Greg M Cole
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.